ANGEL MATTHEW (CEO and President) purchased 231.48K shares of TEMPEST THERAPEUTICS, INC. on the open market
Open‑market purchase worth $500.0K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/23/2026ACC: 0001193125-26-279703
DirectorOfficer10% Owner· CEO and President
Since Feb 2026
+694.45K
Net shares
Net buyer
$500.0K
Total acquired
1
Open market trades
1B · 0S
3
Total transactions
694.45K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+231.48K
Price / share
$2.16
Trade value
$500K
% of position
New position
3/24/2026
0.00→231.48K
Total
Net shares
+231.48K
Net value
$500K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 3/24/2026 | P · Purchase | +231.48K | $2.16 | $500K | New position | 0.00 | 231.48K |
| Total | +231.48K | $500K | ||||||
Derivative Transactions2
Series A Warrant (right to buy)
Indirect
Converts to
Common Stock
231.48K shares
Shares
+231.48K
Strike price
2.16
Held after
231.48K
Exercisable
—
3/24/2026
Series B Warrant (right to buy)
Indirect
Converts to
Common Stock
231.48K shares
Shares
+231.48K
Strike price
2.16
Held after
231.48K
Exercisable
—
3/24/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Warrant (right to buy) Indirect | Common Stock231.48K shares | 3/24/2026 | P · Purchase | +231.48K | 2.16 | — | 231.48K |
| Series B Warrant (right to buy) Indirect | Common Stock231.48K shares | 3/24/2026 | P · Purchase | +231.48K | 2.16 | — | 231.48K |